Cited by

• Translational bioinformatics in the era of real-time biomedical, health care and wellness data streams.

  Shameer K, Badgeley MA, Miotto R, Glicksberg BS, Morgan JW, Dudley JT. Shameer K, et al. Brief Bioinform. 2017 Jan;18(1):105-124. doi: 10.1093/bib/bbv118. Epub 2016 Feb 14. Brief Bioinform. 2017. PMID: 26876889 Free PMC article.
• Unravelling biology and shifting paradigms in cancer with single-cell sequencing.

  Baslan T, Hicks J. Baslan T, et al. Nat Rev Cancer. 2017 Aug 24;17(9):557-569. doi: 10.1038/nrc.2017.58. Nat Rev Cancer. 2017. PMID: 28835719 Review.
• [Mutational tumor profiles beyond organ and tissue specificity: implications for diagnostics and clinical study design].

  Klauschen F. Klauschen F. Pathologe. 2014 Nov;35 Suppl 2:277-80. doi: 10.1007/s00292-014-2027-7. Pathologe. 2014. PMID: 25394977 Review. German.
• The combinatorial complexity of cancer precision medicine.

  Klauschen F, Andreeff M, Keilholz U, Dietel M, Stenzinger A. Klauschen F, et al. Oncoscience. 2014 Jul 23;1(7):504-9. doi: 10.18632/oncoscience.66. eCollection 2014. Oncoscience. 2014. PMID: 25594052 Free PMC article.
• Application of next-generation sequencing technology to precision medicine in cancer: joint consensus of the Tumor Biomarker Committee of the Chinese Society of Clinical Oncology.

  Zhang X, Liang Z, Wang S, Lu S, Song Y, Cheng Y, Ying J, Liu W, Hou Y, Li Y, Liu Y, Hou J, Liu X, Shao J, Tai Y, Wang Z, Fu L, Li H, Zhou X, Bai H, Wang M, Lu Y, Yang J, Zhong W, Zhou Q, Yang X, Wang J, Huang C, Liu X, Zhou X, Zhang S, Tian H, Chen Y, Ren R, Liao N, Wu C, Zhu Z, Pan H, Gu Y, Wang L, Liu Y, Zhang S, Liu T, Chen G, Shao Z, Xu B, Zhang Q, Xu R, Shen L, Wu Y, Tumor Biomarker Committee OBOCSOCOC. Zhang X, et al. Cancer Biol Med. 2019 Feb;16(1):189-204. doi: 10.20892/j.issn.2095-3941.2018.0142. Cancer Biol Med. 2019. PMID: 31119060 Free PMC article.